Harvey Risch, an epidemiologist respected for his cancer research, promoted the use of hydroxychloroquine during the pandemic ...
Aljin agreed to it because, although the set-up was fake, Khalil really did have cancer. She was told this video would help ...
A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.
Genetics, the microbiome, and low screening rates may be factors in the increase, experts say. Here are risk factors for the ...
Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
The actress opened up about the importance of connection and community at the San Antonio Breast Cancer Symposium with ...
Alcohol significantly increases a person's risk of developing a wide range of cancers, and that risk rises further as more is ...
Troy’s gut instinct told him: don’t give in—get busy. He began working closely on treatment with his oncologist, as well as ...
Just The News on MSN
Trump's cancer panel chair wants 'more formal studies' of ivermectin, HCQ as treatment options
"I don't want to overpromise" because "anecdotal reports" may not include failures, Dr. Harvey Risch exclusively tells Just ...
Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.
The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...
A nurse who was given a 20% chance of surviving after being diagnosed with a rare form of cancer as a child has urged people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results